1. [Treatment of older patients with acute myelogenous leukaemia without allogenic stem cell transplantation at Akershus University Hospital].
- Author
-
Storlien T and Dahm AEA
- Subjects
- Aged, Humans, Treatment Outcome, Antineoplastic Combined Chemotherapy Protocols adverse effects, Hospitals, Leukemia, Myeloid, Acute therapy, Leukemia, Myeloid, Acute drug therapy, Hematopoietic Stem Cell Transplantation methods
- Abstract
Background: It is uncertain what the best treatment is for older patients with acute myeloid leukaemia who are not candidates for allogeneic stem cell transplantation. The purpose of the study was to examine the treatment practices for this patient group at Akershus University Hospital, as well as survival according to treatment choices and the genetic risk of a tumour., Material and Method: The study is based on a review of the medical records of patients aged 65 and older with recently diagnosed acute myeloid leukaemia treated without allogeneic stem cell transplantation at Akershus University Hospital from 1 January 2006 to 1 January 2021., Results: We included 151 out of 156 identified patients. The median age was 76 years, 42 patients (28 %) received intensive chemotherapy, 38 (25 %) received low-intensity chemotherapy and 71 (47 %) received supportive care only. Supportive care was mainly given in the early part of the period. From 2014 onwards, low-intensity chemotherapy made up a significant part of the treatment. Tumour genetic analyses were available for 88 patients, of which 17, 47 and 24 had a favourable, intermediate and unfavourable genetic risk of a tumour respectively. None of the patients with an unfavourable genetic risk of a tumour survived for 2 years. There were no statistically significant differences in survival between low-intensity and intensive chemotherapy. In the group with a favourable genetic risk of a tumour, the median survival was 573 days with intensive chemotherapy (n=12) and 101 days with low-intensity chemotherapy (n=4) (p=0.09). Patients treated with intensive chemotherapy were in hospital the longest., Interpretation: The results suggest that knowledge of the genetic risk of a tumour is useful when choosing treatment for older patients with acute myeloid leukaemia.
- Published
- 2023
- Full Text
- View/download PDF